Visual outcomes of polypoidal choroidal vasculopathy with prompt or deferred treatments or without treatments

UMIN ID: UMIN000031352

Registered date:01/03/2018

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Polypoidal choroidal vasculopathy
• Date of first enrollment: 2009/04/01
• Target sample size: 50
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

photodynamic therapy (PDT)
anti-vascular endothelial growth factor (VEGF) therapy

Outcome(s)

• Primary Outcome: (1) Changes in best-corrected visual acuity (2) Timing and the number of treatments

Key inclusion & exclusion criteria

• Age minimum: 50years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1. past history of photocoagulation or photodynamic therapy or anti-vascular endothelial growth factor therapy 2. presence of other macular diseases 3. presence of uveitis 4. past history of vitrectomy 5. hazy media causing difficulties in fun dus examinations 6. pregnant or planned for pregnancy 7. undergone intraocular surgeries within the previous 6 months 8. judged by the investigator to be ineligible for other reasons

Related Information

• Primary Sponsor: Nagoya City University Graduate School of Medical Sciences
• Source(s) of Monetary Support: Nagoya City University Graduate School of Medical Sciences